Clinical trials
Recruiting Phase 1 Amyotrophic Lateral Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| 1ST Biotherapeutics, Inc. | 1 |
| AC Immune SA | 1 |
| Amylyx Pharmaceuticals Inc. | 1 |
| Celosia Therapeutics Pty Ltd | 1 |
| Hong Chen | 1 |
| Insmed Gene Therapy LLC | 1 |
| Johns Hopkins University | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Novabio Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 16 |
| Motor Neuron Disease | 3 |
| Alzheimer Disease | 1 |
| Frontotemporal Dementia | 1 |
| Neurodegenerative Diseases | 1 |
| TDP-43 Proteinopathies | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.